Concepedia

Adriane Schilling

AS

Statistics

Publications

10

Citations

663

H-Index

10

Active since

1988

Affiliations

Amicus Therapeutics (United States)(Current)

United States Pharmacopeial Convention

Adriane Schilling is an author at Amicus Therapeutics (United States) specializing in life sciences, pharmacology, and pharmacological chaperone therapy.

Publications per year

1988–2019

10

Publications

10

The pharmacological chaperone 1‐deoxygalactonojirimycin increases α‐galactosidase A levels in Fabry patient cell lines

John J. Flanagan, Adriane Schilling, Hui‐Hwa Chang et al. · Journal of Inherited Metabolic Disease · 2009 · 169 citations

, , +10

The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of <b>β</b>‐glucosidase

Richie Khanna, Elfrida R. Benjamin, Lee Pellegrino et al. · FEBS Journal · 2010 · 158 citations · Full text

, , +16

Co-administration With the Pharmacological Chaperone AT1001 Increases Recombinant Human α-Galactosidase A Tissue Uptake and Improves Substrate Reduction in Fabry Mice

Elfrida R. Benjamin, Richie Khanna, Adriane Schilling et al. · Molecular Therapy · 2012 · 93 citations · Full text

, , +15

Improved efficacy of a next-generation ERT in murine Pompe disease

Su Xu, Yi Lun, Michelle Frascella et al. · JCI Insight · 2019 · 82 citations · Full text

, , +17

Synthesis and structure–activity relationships of 3,4-diaminocyclobut-3-ene-1,2-dione CXCR2 antagonists

J. Robert Merritt, Laura L. Rokosz, Kingsley H. Nelson et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 47 citations · Full text

, , +10

1–5 of 10